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OBSERVATIONS
Hypoglycemia in
Patients With
Diabetes on
Antidiabetic
Medications Who
Fast for Laboratory
Tests
W
e would like to report the results
ofapilotstudythatweundertook
to evaluate the risk of hypoglyce-
mia in patients with diabetes on antidia-
betic medications because of the repeated
callsfromourlaboratoryreportingcritical
glucose results, typically after patients
who had come earlier for blood tests
had already left the laboratory. We have
become increasingly concerned about
these occurrences and realized that our
patients may not be adequately educated
on the proper preparation for tests re-
quiring overnight fasting.
Patients with diabetes are generally
given instructions regarding medication
adjustments when they fast overnight for
surgical or diagnostic procedures, but we
became concerned that there may not be
such instructions for overnight fasting for
laboratory tests. It could be argued that
some clinicians may take the initiative of
providing such instructions. However,
being diabetes specialists ourselves, we
acknowledge that we had not paid ade-
quateattentiontothisissue.Similarly,from
talking with diabetes educators (S.A., per-
sonal communications), we realized that
this educational piece is not included in
traditional curricula. Extensive literature
search retrieved no publications on this
critical issue or educational guidelines
on how to prepare patients with diabetes
for overnight fasting for laboratory tests.
(The literature search was undertaken by
senior and experienced librarians at both
libraries of the Saint Francis Medical Cen-
ter, Cape Girardeau, Missouri, and the
Sparrow Hospital, Lansing, Michigan.)
Hence, we hypothesized that this could
be an overlooked quality assurance prob-
lem and subsequently undertook this ret-
rospective study.
Over a 21-month period, our labo-
ratory (which does not record fasting
status) identiﬁed 55 patients with hypo-
glycemia between 8:00 A.M. to 12:00 P.M.
Upon retrospective chart reviews and
telephone interviews, 39 of these patients
w e r ef o u n dt ob eo na n t i d i a b e t i cm e d i c a -
tions: 15 recalled being fasting,4 nonfast-
ing, and 20 were uncertain. The range of
hypoglycemia in the patients who recalled
being fasting or possibly fasting (n 5 35)
was 69–30 mg/dL: 23 results ,60,
11 ,50, and 6 ,40 mg/dL (66, 31, and
17%, respectively). Seven patients re-
called having autonomic hypoglycemic
symptomsbutnonehadachangeintheir
level of consciousness, and none needed
assistance. No patients recalled making
adjustments to their antidiabetic medica-
tions the night before or the morning of
the test.
These ﬁndings indicate that patients
on antidiabetic medications are at risk for
developing hypoglycemia while fasting
for laboratory testing. While we are not
certain of the causes of hypoglycemia in
our patients, a possible explanation for the
ensuing hypoglycemia is the lingering
effects of antidiabetic medications during
aprolonged fast,ashepatic glycogen stores
may begin to wane, and release of hepatic
glucose may get impaired.
We believe that while the liver can
provideglucoseduringprolongedfasting,
this usually is physiologically facilitated
by signiﬁcant reductions in insulin secre-
tion to the nadir. In patients on insulin,
especially basal insulin the night before,
or on long-acting sulphonylurias, this
protective physiologic mechanism is im-
paired or eliminated, and release of glu-
cose from the liver is thus impaired. We
believe that thisisparticularlymore likely
to occur in patients with long-standing
diabetes who are vulnerable to have im-
paired glucagon secretion, and in patients
withautonomicneuropathywhoareatrisk
of impaired epinephrine release.
S i n c ew er e a l i z e d these recurring
events in our patients, we implemented
the following educational program at our
practice: 1) more frequent glucose moni-
toring during the morning hours (until
the fasting is broken) and cancelling the
laboratory tests if necessary; 2)a v o i d i n g
anytypeofinsulin,whethershort-orlong-
acting,onthemorningofthetest (patients
are routinely instructed to skip scheduled
short-acting insulin when skipping a meal
but are not always certain about basal in-
sulin); 3) taking less long-acting insulin at
night; and 4) reducing or omitting evening
doses of sulphonylurias.
In conclusion, we believe that hypo-
glycemia resulting from fasting for labo-
ratorytestsisanoverlookedproblem.The
potential serious harm to patients should
be of particular interest to risk managers,
laboratories, clinicians, and diabetes edu-
cators. Clinicians and diabetes educators
should instruct their patients about prep-
aration for fasting for laboratory tests in-
cluding close glucose monitoring and
adjustment of antidiabetic medications.
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